MYD88 and neoplasm: Although the expression of MCP-1 was also reduced in LLC tumors grown in MyD88−/− mice (Figure 5A, lanes 5–7), there was no significant difference in either serum MCP-1 level or tumor volume between MyD88−/− and WT mice (Figures 5B,C).